UNC-2025 - CAS 1429881-91-3
Catalog number: 1429881-91-3
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C28H40N6O
Molecular Weight:
476.669
COA:
Inquire
Targets:
FLT3
Description:
UNC-2025 is a novel potent and highly orally bioavailable Mer/FLT3 dual inhibitor, capable of inhibiting Mer phosphorylation in vivo, following oral dosing as demonstrated by pharmaco-dynamic (PD) studies examining phospho-Mer in leukemic blasts from mouse bone marrow. Kinome profiling versus more than 300 kinases in vitro and cellular selectivity assessments demonstrate that UNC-2025 has similar subnanomolar activity against Flt3, an additional important target in acute myelogenous leukemia (AML), with pharmacologically useful selectivity versus other kinases examined.
Purity:
0.98
Appearance:
white solid powder
Synonyms:
UNC2025, UNC2025, UNC 2025
MSDS:
Inquire
InChIKey:
MJSHVHLADKXCML-UHFFFAOYSA-N
InChI:
InChI=1S/C28H40N6O/c1-3-4-13-29-28-30-18-25-26(20-34(27(25)31-28)23-9-11-24(35)12-10-23)22-7-5-21(6-8-22)19-33-16-14-32(2)15-17-33/h5-8,18,20,23-24,35H,3-4,9-17,19H2,1-2H3,(H,29,30,31)
Canonical SMILES:
CCCCNC1=NC=C2C(=CN(C2=N1)C3CCC(CC3)O)C4=CC=C(C=C4)CN5CCN(CC5)C
Current Developer:
University of North Carolina at Chapel Hill
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related FLT3 Products


CAS 1457983-28-6 G-749

G-749
(CAS: 1457983-28-6)

G-749 potently inhibits autophosphorylation of FLT3 with IC50 of ≤8 nM. In leukemia cells, G-749 shows antiproliferative activity by inducing apoptosis.

CAS 1327167-19-0 BPR1J-097

BPR1J-097
(CAS: 1327167-19-0)

BPR1J-097 is a novel potent FLT3 inhibitor with an IC50 of 11 nM.

CAS 387867-13-2 Tandutinib

Tandutinib
(CAS: 387867-13-2)

Tandutinib, also known as MLN 518, is a piperazinyl quinazoline receptor tyrosine kinase inhibitor with antineoplastic activity. Tandutinib inhibits the autopho...

FLT3-IN-1
(CAS: 1370256-78-2)

FLT3-IN-1, a Flt3 inhibitor, has been found to have week activity against T lymphoma Jurkat cells and human lung cancer PC-9 and H292 cells. IC50: 10 nM (in vit...

CAS 950769-58-1 Quizartinib

Quizartinib
(CAS: 950769-58-1)

This active molecular also known as AC220 and AC010220, is developed as a new second-generation FLT3 inhibitor for Flt3(ITD/WT) with IC50 of 1.1 nM/4.2 nM, ten ...

CAS 1839150-56-9 CHMFL-FLT3-122

CHMFL-FLT3-122
(CAS: 1839150-56-9)

CHMFL-FLT3-122 is a potent and selective FLT3 inhibitor (IC50 = 40 nM) with >10-fold and 170-fold selectivity for FLT3 over BTK kinase and c-KIT kinase. It caus...

CAS 1204918-72-8 SB1317

SB1317
(CAS: 1204918-72-8)

SB1317 is a novel small molecule potent CDK/JAK2/FLT3 inhibitor. It dose-dependently inhibits signaling pathways downstream of CDKs, JAK2 and FLT3 in cancer cel...

CAS 630124-46-8 AST 487

AST 487
(CAS: 630124-46-8)

AST487 is a Ret kinase inhibitor/FLT3 inhibitor, which displays high selectivity and potency toward FLT3 as a molecular target, and which could potentially be u...

Chemical Structure

CAS 1429881-91-3 UNC-2025

Quick Inquiry

Verification code

Featured Items